PHATHOM PHARMACEUTICALS INC. - COMMON STOCK
5.6700
21-February-25 16:45:00
15 minutes delayed
Stocks
+0.1300
+2.35%
Today's range
5.5300 - 5.7550
ISIN
N/A
Source
NASDAQ
-
Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference
29 Jan 2025 08:00:33 By Nasdaq GlobeNewswire
-
11 Dec 2024 08:00:00 By Nasdaq GlobeNewswire
-
Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
07 Nov 2024 08:00:01 By Nasdaq GlobeNewswire
-
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
04 Nov 2024 08:00:14 By Nasdaq GlobeNewswire
-
28 Oct 2024 08:00:49 By Nasdaq GlobeNewswire
-
27 Oct 2024 12:00:40 By Nasdaq GlobeNewswire
-
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
29 Aug 2024 08:00:43 By Nasdaq GlobeNewswire
-
19 Aug 2024 08:00:19 By Nasdaq GlobeNewswire
-
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
08 Aug 2024 08:00:08 By Nasdaq GlobeNewswire
-
30 Jul 2024 08:00:01 By Nasdaq GlobeNewswire
-
29 Jul 2024 07:59:41 By Nasdaq GlobeNewswire
-
18 Jul 2024 08:00:50 By Nasdaq GlobeNewswire
-
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
28 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
15 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
09 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
29 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
26 Mar 2024 08:00:05 By Nasdaq GlobeNewswire
-
07 Mar 2024 08:00:50 By Nasdaq GlobeNewswire
-
29 Feb 2024 08:00:49 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >